Ironing Out the Future: AMAG Hopes Its Novel Iron Therapy For CKD Wins Approval Next Week
AMAG’s iron therapy for CKD awaits a June 29 FDA action date; if approved, the product represents significant opportunities for growth.
AMAG’s iron therapy for CKD awaits a June 29 FDA action date; if approved, the product represents significant opportunities for growth.